Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

214.97
BATS BZX Real-Time Price
As of 10:42am ET
 +0.42 / +0.20%
Today’s Change
124.82
Today|||52-Week Range
230.72
+67.89%
Year-to-Date

Today’s Trading

Previous close214.55
Today’s open215.06
Day’s range214.48 - 215.81
Volume4,675
Average volume (3 months)753,890
Market cap$31.3B
Data as of 10:42am ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+12.42%
Earnings growth (next 5 years)+15.60%
Revenue growth (last year)+8.05%
P/E ratio41.0
Price/Sales7.90
Price/Book14.28

Competitors

----
BIVVBioverativ Inc+0.20+0.37%
EXASExact Sciences Corp+0.02+0.04%
BLUEbluebird bio Inc+1.70+0.92%
Data as of 10:42am ET, 12/14/2017

Financials

Next reporting dateJanuary 30, 2018
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts